Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06548386 · ClinicalTrials.gov registry record · NA
Feasibility and Accuracy of a Novel Pleural Drain Gas Analyzer in Detecting Air Leaks
A NA study of Pneumothorax and Air Leak From Lung, sponsored by Lung Healing Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT06548386: Recruiting NA study of Pneumothorax and Air Leak From Lung, sponsored by Lung Healing Technologies.
NCT06548386 is a NA study of Pneumothorax and Air Leak From Lung that is actively recruiting participants, run by Lung Healing Technologies. The registered enrollment target is 33 participants, below the 639-participant average among 6 other Pneumothorax trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06548386, a NA study of Pneumothorax and Air Leak From Lung, is actively recruiting participants, sponsored by Lung Healing Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to assess the clinical feasibility of a novel, reusable, low cost gas analyzer that detects breath in chest drains in order to diagnose and heal air leaks. The investigators have developed prototype gas analyzers that attach to the outlet of any analog chest drain, and can be connected temporarily to the sampling port. They detect breath by measuring CO2, O2, and pressure, in order to supplement the information provided by the bubbles in the water seal.
Primary Outcome
Whether gas analysis can accurately assess for air leak
Conditions Studied
Interventions
- DEVICE Pleural gas analysis
Study Locations (1)
Illinois
- Endeavor Health - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2025-02-05 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06548386 shows while recruiting
NCT06548386 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 639-participant average among 6 other Pneumothorax trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Pneumothorax appearing as the primary indexed condition, and to 1 intervention - of which Pleural gas analysis is the first listed.
NCT06548386 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06548386 about?
NCT06548386 is a clinical study titled "Feasibility and Accuracy of a Novel Pleural Drain Gas Analyzer in Detecting Air Leaks". The goal of this study is to assess the clinical feasibility of a novel, reusable, low cost gas analyzer that detects breath in chest drains in order to diagnose and heal air leaks. The investigators have developed prototype gas analyzers that attach to the outlet of any analog chest drain, and can ...
What is the current status of trial NCT06548386?
This trial is currently recruiting. It is a NA study. The enrollment target is 33 participants. The study started on 2025-02-05. Estimated completion is 2026-06.
What conditions does trial NCT06548386 study?
This clinical trial studies the following conditions: Pneumothorax, Air Leak From Lung.
What interventions are being tested in trial NCT06548386?
The interventions under investigation include: Pleural gas analysis (DEVICE).
Who is sponsoring clinical trial NCT06548386?
This trial is sponsored by Lung Healing Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06548386 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumothorax
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Drainage Amount for Removal of Thoracostomy Tube
COMPLETED · NA
-
Effect of Rapid Rollover on Pneumothorax After CT-Guided Lung Biopsy
COMPLETED · NA
-
Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting
RECRUITING
-
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
RECRUITING
-
Study of the Disease Process of Lymphangioleiomyomatosis
RECRUITING
-
Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI